Skip to content

Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo

Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo - Ardox-X® Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35463
Enrollment
50
Registered
2011-10-24
Start date
2011-10-27
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tandplakvorming de novo plaque formation

Interventions

One week of no mechanical oral hygiene but rinsing twice daily for one minute.

Sponsors

ACTA dental research B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • >= 18 years • Systemically healthy • minimum of 5 teeth per quadrant • absence of oral lesions • not participate in other clinical care study • Overnight plaque assessment of Modified Quigley & Hein index score >=2 • No orthodontic appliances (except for retention lingual wire) • No removable (partial) dentures • No prosthetics crowns • No overhanging margins • Signed written-informed consent

Exclusion criteria

Exclusion criteria: • The use of antibiotics during the last 6 months • Dutch Periodontal Screening Index (DPSI) >=3+ • Use of medication possibly influencing normal gingival health • Pregnancy • Smoking • The use of electric toothbrush

Design outcomes

Primary

MeasureTime frame
Primary outcome variable is the Modified Quigley & Hein index

Secondary

MeasureTime frame
Secondary outcome variable is: • The Bleeding on marginal probing (BOMP) index. • Results from the VAS questionnaire to evaluate the subject*s attitude towards the used products. • Microbiological analysis to monitor shifts in the composition of the microbiota

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)